ULK4
Basic information
Region (hg38): 3:41246599-41962130
Links
Phenotypes
GenCC
Source:
- prostate cancer (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ULK4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 15 | ||||
missense | 72 | 10 | 91 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 3 | 5 | |||
non coding | 2 | |||||
Total | 0 | 0 | 72 | 22 | 15 |
Variants in ULK4
This is a list of pathogenic ClinVar variants found in the ULK4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-41246940-C-T | not specified | Uncertain significance (Jan 25, 2023) | ||
3-41246976-C-T | not specified | Uncertain significance (Mar 21, 2022) | ||
3-41246981-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
3-41249491-A-T | not specified | Uncertain significance (Apr 10, 2023) | ||
3-41249501-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
3-41249508-G-A | not specified | Uncertain significance (Mar 31, 2022) | ||
3-41249520-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
3-41398137-A-G | not specified | Uncertain significance (Apr 25, 2022) | ||
3-41398155-T-C | not specified | Uncertain significance (Mar 06, 2023) | ||
3-41398183-G-A | not specified | Uncertain significance (May 11, 2022) | ||
3-41398186-T-C | not specified | Uncertain significance (Feb 12, 2024) | ||
3-41398197-T-C | not specified | Uncertain significance (Sep 06, 2022) | ||
3-41398242-A-G | not specified | Uncertain significance (Aug 08, 2022) | ||
3-41455519-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
3-41455535-T-C | not specified | Uncertain significance (Jul 12, 2022) | ||
3-41455547-G-C | not specified | Uncertain significance (Oct 05, 2023) | ||
3-41455578-T-C | Benign (Jul 10, 2017) | |||
3-41455585-G-C | not specified | Uncertain significance (Nov 03, 2023) | ||
3-41463106-A-G | not specified | Uncertain significance (May 25, 2022) | ||
3-41463164-G-C | not specified | Likely benign (Aug 21, 2023) | ||
3-41463230-G-A | ULK4-related disorder | Likely benign (Sep 17, 2019) | ||
3-41566033-T-A | not specified | Uncertain significance (Jun 29, 2023) | ||
3-41566046-T-C | not specified | Uncertain significance (Feb 15, 2023) | ||
3-41566050-C-T | Benign/Likely benign (Nov 01, 2023) | |||
3-41566066-A-T | not specified | Uncertain significance (Oct 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ULK4 | protein_coding | protein_coding | ENST00000301831 | 36 | 715833 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.43e-38 | 0.0000869 | 124190 | 6 | 1112 | 125308 | 0.00447 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.906 | 722 | 657 | 1.10 | 0.0000336 | 8260 |
Missense in Polyphen | 167 | 157.83 | 1.0581 | 2081 | ||
Synonymous | -0.413 | 251 | 243 | 1.03 | 0.0000123 | 2465 |
Loss of Function | 0.882 | 62 | 70.0 | 0.886 | 0.00000332 | 894 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00502 | 0.00491 |
Ashkenazi Jewish | 0.00279 | 0.00278 |
East Asian | 0.00413 | 0.00403 |
Finnish | 0.00645 | 0.00640 |
European (Non-Finnish) | 0.00571 | 0.00557 |
Middle Eastern | 0.00413 | 0.00403 |
South Asian | 0.00378 | 0.00366 |
Other | 0.00366 | 0.00362 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in the remodeling of cytoskeletal components, such as alpha-tubulin, and in this way regulates neurite branching and elongation, as well as cell motility. {ECO:0000269|PubMed:24284070}.;
- Disease
- DISEASE: Note=Various anomalies in ULK4 gene have been reported for several cases of schizophrenia, schizophrenia plus bipolar disorder and autism. ULK4 gene has been proposed to be a rare susceptibility risk factor for a range of psychiatric diseases including schizophrenia. {ECO:0000269|PubMed:24284070}.;
Intolerance Scores
- loftool
- 0.979
- rvis_EVS
- 1.71
- rvis_percentile_EVS
- 96.44
Haploinsufficiency Scores
- pHI
- 0.115
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.407
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.923
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Ulk4
- Phenotype
- craniofacial phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- microtubule cytoskeleton organization;protein phosphorylation;regulation of neuron projection development;regulation of MAPK cascade;regulation of JNK cascade;regulation of protein kinase C signaling;regulation of p38MAPK cascade;regulation of neuron migration
- Cellular component
- Molecular function
- protein serine/threonine kinase activity;ATP binding